The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii

Antimicrob Agents Chemother. 2004 Dec;48(12):4919-21. doi: 10.1128/AAC.48.12.4919-4921.2004.

Abstract

The lactoferrin-derived peptide hLF(1-11), but not its control peptide, was highly effective against five multidrug-resistant Acinetobacter baumannii strains in vitro (3 to 4 log reduction) and against four of these strains in an experimental infection in mice (2 to 3 log reduction). Therefore, this peptide is a promising candidate as a novel agent against infections with multidrug-resistant A. baumannii.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / drug effects*
  • Amino Acid Sequence
  • Animals
  • Colony-Forming Units Assay
  • Dose-Response Relationship, Drug
  • Drug Resistance, Multiple, Bacterial
  • Lactoferrin
  • Male
  • Mice
  • Molecular Sequence Data
  • Peptide Fragments / therapeutic use*

Substances

  • Peptide Fragments
  • lactoferrin (1-11), human
  • Lactoferrin